Grant: Master's Award: Canada Graduate Scholarships
University of Guelph
$17,500.00
Depletion of RAD51 in truncated BRCA2 mutants: Molecular analysis and implications for cancer-linked mutations
EF 2015-16
Résumé
Inherited mutations in the breast cancer type 2 (BRCA2) susceptibility gene predispose to breast, ovarian and other cancers. Loss of BRCA2 perturbs key steps in DNA double strand break repair by RAD51-mediated homologous recombination (HR). The vast majority of BRCA2 mutations result in a truncated, cytoplasmically localized protein due to loss of the C-terminal nuclear localization signals. Therefore the non-functional nature of most cancer-associated BRCA2 truncation mutants (including the most frequent mutant, BRCA26174delT) might simply result from their inability to regulate RAD51-mediated HR in the nucleus. However, this default explanation is inconsistent with our recent results showing that cells expressing truncated BRCA26174delT are significantly depleted for RAD51 protein and compromised for HR. We hypothesize that RAD51 depletion is an early event that compromises HR, predisposing to genomic instability and tumour development. The objective is to elucidate the molecular basis for RAD51 depletion by truncated BRCA2 by determining 1) what structural features of mutated BRCA2 cause RAD51 depletion; 2) if other HR protein levels are affected as well; and 3) the mechanism of RAD51 depletion in the cell. This research features short and long-term impacts aimed at defining new mechanisms by which BRCA2 truncation mutants compromise genome integrity and offers new strategies for eliminating pre-cancerous cells in patients harboring inherited BRCA2 truncation mutants.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
349924
Name
Bush Natasha D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Depletion of RAD51 in truncated BRCA2 mutants: Molecular analysis and implications for cancer-linked mutations
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Ovarian Cancers; Brca2; Breast; Dna Repair; Dna Replication; Double-Stranded Dna Breaks; Genome Integrity; Homologous Recombination; Neoplastic Transformation; Rad51; Rad52-Epistasis Group Proteins
Abstract
Inherited mutations in the breast cancer type 2 (BRCA2) susceptibility gene predispose to breast, ovarian and other cancers. Loss of BRCA2 perturbs key steps in DNA double strand break repair by RAD51-mediated homologous recombination (HR). The vast majority of BRCA2 mutations result in a truncated, cytoplasmically localized protein due to loss of the C-terminal nuclear localization signals. Therefore the non-functional nature of most cancer-associated BRCA2 truncation mutants (including the most frequent mutant, BRCA26174delT) might simply result from their inability to regulate RAD51-mediated HR in the nucleus. However, this default explanation is inconsistent with our recent results showing that cells expressing truncated BRCA26174delT are significantly depleted for RAD51 protein and compromised for HR. We hypothesize that RAD51 depletion is an early event that compromises HR, predisposing to genomic instability and tumour development. The objective is to elucidate the molecular basis for RAD51 depletion by truncated BRCA2 by determining 1) what structural features of mutated BRCA2 cause RAD51 depletion; 2) if other HR protein levels are affected as well; and 3) the mechanism of RAD51 depletion in the cell. This research features short and long-term impacts aimed at defining new mechanisms by which BRCA2 truncation mutants compromise genome integrity and offers new strategies for eliminating pre-cancerous cells in patients harboring inherited BRCA2 truncation mutants.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bush, Natasha D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~